11 hasil untuk "Dylan Hansen"
Menampilkan 1–11 · 0,14 detik · RSS
-
Artikel Jurnal
Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
Abstract Background To describe the epidemiology, determinants and survival impact of gastric antral vascular ectasia (GAVE) in systemic sclerosis (SSc). Methods Consecutive SSc patients prospectively enrolled in the Australian Scleroderma Cohort Study (ASCS) were included. Univariable and…
-
Artikel Jurnal
The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis
Objective Our objective was to define the frequency and impact of multimorbidity in systemic sclerosis (SSc). Method Australian Scleroderma Cohort Study participants meeting American College of Rheumatology/EULAR criteria were included. Charlson Comorbidity Index scores were calculated at each…
-
Artikel Jurnal
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Abstract Background To quantify the financial cost of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc). Methods Healthcare use was captured through data linkage, wherein clinical data for SSc patients enrolled in the Australian Scleroderma Cohort Study were linked with hospital…
-
Artikel Jurnal
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
Abstract Background Skeletal muscle can be directly affected by systemic sclerosis (SSc); however, a significant burden of SSc-associated myopathy is undetected because clinical parameters such as weakness and creatine kinase (CK) are unreliable biomarkers of muscle involvement. This study presents…
-
Artikel Jurnal Teks lengkap
Predictive Accuracy of Serum N-Terminal Pro-B-Type Natriuretic Peptide Alone and in Combination with Respiratory Function Tests to Identify Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Background/Objectives: Pulmonary arterial hypertension (PAH) occurs in >12% of systemic sclerosis (SSc) patients and has a high mortality. Annual screening for all SSc patients is the standard of care and can include spirometry (RFT), serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and…
-
Artikel Jurnal
Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis
Objective Gastroesophageal reflux disease (GERD) affects up to 90% of patients with systemic sclerosis (SSc). Chronic esophageal acid exposure can result in complications including the formation of esophageal strictures (ES). Proton pump inhibitors can alter gastric acid pH and improve GORD…
-
Artikel Jurnal
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
Abstract Objectives To describe the clinical phenotype and prognosis of people in the Australian Scleroderma (SSc) Cohort Study with pulmonary arterial hypertension (PAH) with or without interstitial lung disease (ILD). Methods Participants meeting ACR/EULAR criteria for SSc were divided into four…
-
Artikel Jurnal
A Multicenter, Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis‐Related Pulmonary Arterial Hypertension—Results From the SPHInX Study
ABSTRACT The SPHInX study is the first‐ever randomized controlled trial (RCT) seeking to inform an area of equipoise regarding the efficacy of oral anticoagulation as adjunct therapy in systemic sclerosis‐related pulmonary arterial hypertension (SSc‐PAH). The SPHInX study was an Australian…
-
Artikel Jurnal
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This study aimed to evaluate the outcomes of patients who achieved LLDAS with clinical activity, serological…
-
Artikel Jurnal
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort
Objective In contrast to relapsing‐remitting patterns, persistently active disease (PAD) is a disease activity pattern in patients with systemic lupus erythematosus (SLE) that is inadequately studied. We sought to identify the frequency and determinants of flare and PAD in SLE. Methods Flare was…